More on VCRT
Data
Financials
News
Click line-items for a historical chart and %
| Sales | 129K |
| Leases | 10K |
| Grants and other | 0 |
| Revenues, Total | 139K |
| Cost of revenue | 72K |
| Gross profit | 67K |
| Research and development | 163K |
| Selling, general and administrative | 1.67M |
| Interest | 1.17M |
| Loss from extinguishment of debt | 0 |
| Total operating expenses | 3.01M |
| Operating Income (Loss), Total | -2.94M |
| Realized | 62K |
| Unrealized | 3.15M |
| Gain (Loss) on Derivative Instruments, Net, Pretax, Total | 3.21M |
| Net income (loss) | 269K |
| Cumulative effect of change in accounting principle | 0 |
| Payable on Series A and Series B preferred stock | -106K |
| Amortization of derivative discount on Series B preferred stock | -249K |
| Value of warrants issued in connection with sales of Series B preferred stock | 0 |
| Total dividends for the benefit of preferred stockholders | -355K |
| Net income (loss) applicable to common stock | -86K |
| Net income (loss) per common share - basic and diluted | 0 |
| Weighted average number of shares of common stock outstanding | 48.61M |
